Concord Drugs

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue13.5311.548.797.3912.62
Expenses12.9111.538.166.6312.88
EBITDA1.450.741.401.530.56
EBIT1.070.441.021.150.17
Profit Before Tax0.610.020.630.77-0.26
Net Profit0.450.070.490.53-0.24
Financial Ratios
Operating Profit Margin10.64%6.41%15.93%20.87%4.44%
Net Profit Margin3.33%0.61%5.57%7.18%-1.90%
Earning Per Share (Diluted)0.520.070.520.56-0.24
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ